Study | Adhesions at SLL |
---|---|
Brown et al. [1] | Number of patients free from de novo adhesions: |
OR 1.49 [1.01, 2.21] | |
Adhesion score at SLL: | |
outcome not analysed | |
Adhesion score reduction at SLL: | |
MD 1.51 [0.32 2.70] | |
Mean % reduction in extent of adhesions: | |
MD 5.10 [−4.67, 14.87] | |
Mean % reduction in severity of adhesions: | |
MD 2.70 [−5.73, 11.13] | |
Improvement in adhesion score: | |
outcome not analysed | |
Worsening in adhesion score: | |
outcome not analysed | |
diZerega et al. [3] | Number of patients free from de novo adhesions: |
outcome not analysed | |
Adhesion score at SLL: | |
outcome not analysed | |
Adhesion score reduction at SLLa: | |
MD 0.10 [−0.50, 0.70] | |
Mean % reduction in extent of adhesions: | |
MD 21.00 [−42.36, 84.36] | |
Mean % reduction in severity of adhesions: | |
MD 47.00 [−15.76, 109.76] | |
Improvement in adhesion score: | |
OR 3.24 [0.86, 12.12] | |
Worsening in adhesion score: | |
OR 0.28 [0.07, 1.21] | |
Trew et al. [5] | Number of patients free from de novo adhesions: |
OR 0.92 [0.55, 1.54] | |
Adhesion score at SLL: | |
MD −0.29 [−2.97, 2.39] | |
Adhesion score reduction at SLL: | |
outcome not analysed | |
Mean % reduction in extent of adhesions: | |
outcome not analysed | |
Mean % reduction in severity of adhesions: | |
outcome not analysed | |
Improvement in adhesion score: | |
outcome not analysed | |
Worsening in adhesion score: | |
outcome not analysed |